open-discussion > Question about clinical labels in OASIS-3
Showing 1-4 of 4 posts
Display:
Results per page:
Jun 29, 2026  12:06 PM | bash - Universidad de Concepcion
Question about clinical labels in OASIS-3

How can I identify whether each subject is cognitively normal or at risk of Alzheimer's disease? Is this information available through a command-line script, or in a separate file?

Jun 29, 2026  01:06 PM | wissal ghachem - Institut Supérieur de Gestion de Sousse
RE: Question about clinical labels in OASIS-3

Hi,


the cognitive/diagnostic status isn't produced by a command-line script — it lives in the clinical data tables you download from the OASIS-3 data browser as spreadsheets (CSV). The download scripts only fetch the imaging/FreeSurfer/PUP files; they don't generate labels.


There are two places to look, both in the ADRC Clinical Data table:



  1. CDR (Clinical Dementia Rating) global score — the quickest "normal vs. impaired" flag:

    • CDR = 0 → cognitively normal

    • CDR = 0.5 → very mild impairment (commonly treated as MCI / at-risk)

    • CDR ≥ 1 → dementia (1 mild, 2 moderate, 3 severe)



  2. dx1–dx5 (coded clinician diagnosis) — more specific than CDR because it gives the etiology. dx1 is the primary diagnosis, with values like "Cognitively normal", "AD dementia", "vascular dementia", plus contributing factors (mood disorder, vitamin deficiency, etc.). So "at risk of AD" specifically means a CDR > 0 with dx1 pointing toward AD dementia / uncertain dementia, rather than just any impairment.

How to get it:



  1. Open the OASIS-3 project in the data browser (central.xnat.org).
  2. Load the Subjects and ADRC Clinical Data tables.
  3. Export as a Spreadsheet (CSV). You'll get columns like cdr, dx1dx5, mmse, ageAtEntry, plus a session label.

One important detail: OASIS-3 is longitudinal, so each clinical row is tagged with the subject ID + "days from entry" (the dXXXX suffix), and a subject's status can change over time. To label a given scan, match by subject ID and pick the clinical assessment closest in days-from-entry to that MR/PET session.


All of this is documented in the OASIS-3 Imaging Data Dictionary (the "ADRC Clinical Data / dx1–dx5" and CDR sections) on oasis-brains.org.


Hope this helps.

Jun 29, 2026  03:06 PM | saif_khan
RE: Question about clinical labels in OASIS-3

I will download the ADRC Clinical Data spreadsheet and use the subject ID together with the days-from-entry information to match the clinical assessments to the corresponding MRI/PET sessions. Since OASIS-3 is longitudinal, I will select the clinical assessment closest to each imaging session when assigning labels.


Thank you also for pointing me to the Imaging Data Dictionary and the ADRC Clinical Data documentation. This information is very useful for my study.


 

Jul 6, 2026  05:07 PM | MohammedYusuf Modan
Subject: Fully HIPAA compliant Deployment for OASIS-3 Longitudinal Data Mapping
Hi Saif,

We have the exact technical infrastructure required to instantly accelerate your OASIS-3 neuroimaging research and ADRC Clinical Data workflows.

To ensure your study can efficiently map subject IDs and calculate "days-from-entry" alignments to the corresponding MRI/PET sessions, we can deploy a dedicated, locked-down research "Spoke" tailored specifically for your team.

Our Research Setup Engine will bypass the burden of building a local data environment so you can focus entirely on selecting the clinical assessments closest to each imaging session. Your deployment will include:


  • Secure Python FastAPI Backend: A dedicated, containerized environment to safely and rapidly execute your longitudinal data parsing and mapping scripts.

  • The BigQuery "Evidence Lake": A highly secure, centralized data storage pool designed for sub-second data retrieval and structuring complex, multi-year datasets.

  • Zero-Trust Processing & Ephemeral Memory: Our architecture ensures that data processing sessions are instantly wiped from local memory once your data is securely routed to the Evidence Lake, maintaining absolute data privacy.


Additionally, should your neuroimaging research ever scale into active clinical application, please note that this same infrastructure natively supports our advanced AI clinical documentation and autonomous compliance monitoring modules, which can be activated on demand.

Let us know if you would like us to provision this secure environment for your study, and we can immediately initiate the setup.

 

Best,

— Manager, Quantum Security Syndicate-m Ascent Enterprise, LLC Secure Posture Portal: http://www.quantumaudit.health Direct Support: support@quantumaudit.health